Clinical Trials Directory

Trials / Completed

CompletedNCT00743587

A Study To Assess The Ability Of Tramadol, Naproxen And Oxycodone To Affect The Pain Thresholds Of Patients With Osteoarthritis Of The Thumb

A Randomized, Double-Blind, Placebo And Active Controlled Methodology Study Investigating The Effects Of Tramadol And Naproxen On The Pain Thresholds Of Patients With Severe Pain Due To Osteoarthritis Of The Thumb

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
36 (actual)
Sponsor
Pfizer · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine if the measurement of pressure pain thresholds, in patients suffering osteoarthritis of the thumb, can be used to assess the activity of potential analgesic agents after a single dose. The study will use agents known to give pain relief in osteoarthritis as positive controls. These agents are: tramadol, naproxen and oxycodone.

Conditions

Interventions

TypeNameDescription
DRUGPlaceboOral, a double-dummy approach will be used to maintain the blind between active tablet and capsule doses
DRUGOxycodoneOral, 1 x 20mg controlled-release tablets
DRUGTramadolOral, 2 x 50mg immediate release capsules
DRUGNaproxenOral, 1 x 500mg enteric-coated

Timeline

Start date
2008-09-01
Primary completion
2009-03-01
Completion
2009-03-01
First posted
2008-08-29
Last updated
2018-12-04

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT00743587. Inclusion in this directory is not an endorsement.